Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC7 | O00311 | 1/20 | 0.53 |
| ▸ | CDK2 | P24941 | 1/20 | 0.53 |
| ▸ | PARP1 | P09874 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.40 |
| ▸ | SLC22A12 | Q96S37 | 4/20 | 0.40 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.39 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2295440 | 0.92 | CDC7 (0.56) | CDC7CDK2PARP1KDM4EMKNK2 | |
| SCHEMBL31070284 | 0.89 | HPGD (0.52) | CDC7CDK2PARP1KDM4ECYP2C19 | |
| SCHEMBL30866643 | 0.89 | CDC7 (0.54) | CDC7CDK2PARP1KDM4EMKNK2 | |
| SCHEMBL28545337 | 0.89 | HPGD (0.52) | CDC7CDK2PARP1KDM4ECYP2C19 | |
| SCHEMBL28650970 | 0.89 | CDC7 (0.47) | CDC7CDK2PARP1RAPGEF4SLC22A12 | |
| SCHEMBL27144742 | 0.89 | CDC7 (0.54) | CDC7CDK2PARP1KDM4EMKNK2 | |
| SCHEMBL1150333 | 0.87 | CDC7 (0.54) | CDC7CDK2PARP1KDM4ECYP2C19 | |
| SCHEMBL30828406 | 0.87 | CDC7 (0.54) | CDC7CDK2PARP1KDM4ECYP2C19 | |
| SCHEMBL2295522 | 0.84 | CDC7 (0.49) | CDC7CDK2PARP1KDM4EMKNK2 | |
| SCHEMBL13204200 | 0.84 | MKNK2 (0.52) | CDC7CDK2PARP1KDM4EMKNK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7989089-B2 | 2-(9-anthryl)imidazo[4,5-f]-[1,10]phenanthroline (2) or 2-(2-pyridyl)imidazo[4,5-f]-[1,10]phenanthroline (4) | LG DISPLAY CO., LTD. (KR) | 2011-08-02 | — | — | US | disclosed |
| US-20060036114-A1 | Organoboron luminescent compounds and methods of making and using same | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 2006-02-16 | — | — | US | disclosed |
| US-20040265629-A1 | Organic luminescent compounds and methods of making and using same | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 2004-12-30 | — | — | US | disclosed |
| US-20040265628-A1 | Organic luminescent compounds and methods of making and using same | LG DISPLAY CO., LTD. (KP) | 2004-12-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060036114-A1 | Organoboron luminescent compounds and methods of making and using same | SLC43A1, SLC1A5, SLC9B2 | CDC7 3636/4885CDK2 4097/4885PARP1 4069/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.